CDC-Authored Genomics and Precision Health Publications Database
Last data update: Dec 01, 2023. (Total: 4776 publications since 2011)
Query Trace: Metchock B[original query] |
---|
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates.
Kaniga K , Hasan R , Jou R , Vasiliauskien E , Chuchottaworn C , Ismail N , Metchock B , Miliauskas S , VietNhung N , Rodrigues C , Shin S , Simsek H , Smithtikarn S , Ngoc ALT , Boonyasopun J , Kazi M , Kim S , Kamolwat P , Musteikiene G , Sacopon CA , Tahseen S , Vasiliauskait L , Wu MH , VallyOmar S . J Clin Microbiol 2021 60 (1) Jcm0291920 |
Towards Unified Data Exchange Formats for Reporting Molecular Drug Susceptibility Testing.
Bonney W , Price SF , Abhyankar S , Merrick R , Hampole V , Halse TA , DiDonato C , Dalton T , Metchock B , Starks AM , Miramontes R . Online J Public Health Inform 2020 12 (2) e14 |
Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Kandler JL , Mercante AD , Dalton TL , Ezewudo MN , Cowan LS , Burns SP , Metchock B , Cegielski P , Posey JE . Antimicrob Agents Chemother 2018 62 (10) |
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.
Yakrus Mitchell A, Driscoll Jeffrey, McAlister Allison, Sikes David, Hartline Denise, Metchock Beverly, Starks Angela M.Tuberculosis research and treatment 2016 3404860 . Tuberculosis research and treatment 2016 3404860 |
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.
Yakrus Mitchell A, Metchock Beverly, Starks Angela M.Tuberc Res Treat 2015 701786 . Tuberc Res Treat 2015 701786 |
DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay.
McAlister Allison J, Driscoll Jeffrey, Metchock Beverly. J. Clin. Microbiol. 2015 May 53(5) 1752-3 . J. Clin. Microbiol. 2015 May 53(5) 1752-3 |
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Yakrus Mitchell A, Driscoll Jeffrey, Lentz Allison J, Sikes David, Hartline Denise, Metchock Beverly, Starks Angela M. J. Clin. Microbiol. 2014 Jun 52(6) 1932-7 . J. Clin. Microbiol. 2014 Jun 52(6) 1932-7 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Campbell Patricia J, Morlock Glenn P, Sikes R David, Dalton Tracy L, Metchock Beverly, Starks Angela M, Hooks Delaina P, Cowan Lauren S, Plikaytis Bonnie B, Posey James E. Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41 . Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41 |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: